Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dubravka Antova"'
Autor:
Evgenija Mihajloska, Aleksandar Dimkovski, Aleksandra Grozdanova, Ana Vasilevska, Dubravka Antova, Zorica Naumovska, Aleksandra Kapedanovska Nestorovska, Zoran Sterjev, Bashkim Osmani, Ljubica Shuturkova
Publikováno v:
Rheumatology, Vol 62, Iss 3, Pp 150-156 (2024)
Introduction Identifying early predictive factors of how rheumatoid arthritis (RA) patients respond to rituximab (RTX) treatment is crucial for both individual treatment outcome and the improvement of clinical practice overall. This study aimed to id
Externí odkaz:
https://doaj.org/article/1303a86a0c194675bd9fa330eea4fe66
Autor:
Evgenija Mihajloska, Aleksandar Dimkovski, Dubravka Antova, Ana Vasilevska, Aleksandra Grozdanova, Zorica Naumovska, Aleksandra Kapedanovska Nestorovska, Zoran Sterjev, Bashkim Osmani, Ljubica Suturkova
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:539-540
Autor:
Elena Jovanovska-Janeva, Biljana Gerasimovska-Kitanovska, Blagica Pecanova, Natasha Eftimovska-Otovic, Marija Zdravevska, Dubravka Antova, Elena Curakova, Gjulshen Selim, Gjorgi Stojchev, Zvezdana Petronijevik
Publikováno v:
Open Access Macedonian Journal of Medical Sciences; Vol. 8 No. T1 (2020): T1-Thematic Issue "Coronavirus Disease (COVID-19)"; 542-547
BACKGROUND: Antineutrophil cytoplasmatic antibody (ANCA)-associated vasculitis (AAV) has a predilection for the kidney and more than three quarters of patients have renal involvement with rapidly progressive glomerulonephritis. Small-vessel systemic
Autor:
S. Vidinik, G. Bozinovski, L.J. Damjanovska-Krstikj, Gucev Filip, Dubravka Antova, S. Pavlova, A. Karadzova Stojanovska, S. Perchinkova-Mishevska, E. Sandevska, N.G. Jordanovska, M. Bojadzioska, I. Kafedjiska, M. Nikolovska Kotevska, B. Osmani
Publikováno v:
Journal of Autoimmune Diseases and Rheumatology. 8:9-17
Autor:
Dubravka Antova, Snezana Perchinkova-Mishevska, Ljubinka Damjanovska-Krstic, Irena Kafedjiska, Georgi Bozinovski, Filip Gucev, Oliver Nikolov, Fjola Hadjihamza, Bashkim Osmani
Publikováno v:
PRILOZI. 39:69-78
Rheumatoid arthritis is an inflammatory arthritis characterized by synovial tissue inflammation that leads to structural damage and disability. There are several treatment options available, which include glucocorticoids, DMARDs and biologics given a
Autor:
Irena Kafedziska, Anzhelika Stojanovska, Dubravka Antova, Snezhana Mishevska-Perchinkova, Filip Guchev, Mimoza Kotevska Nikolova
Publikováno v:
Macedonian Medical Review. 71:83-90
Introduction. Biologic DMARDs (Disease Modifying Anti Rheumatic Drugs) have shown to be effective in the treatment of rheumatoid arthritis (RA) resistant to the use of synthetic DMARDs. The primary goal of this study wasto assess the long-term safety
Autor:
Filip Guchev, Snezhana Mishevska-Perchinkova, Mimoza Kotevska Nikolova, Anzhelika Stojanovska, Irena Kafedziska, Dubravka Antova
Publikováno v:
American Journal of Internal Medicine. 8:125
Introduction: Biologic DMARDs (Disease Modifying Anti Rheumatic Drugs) have shown to be effective in the treatment of rheumatoid arthritis (RA) resistant to the use of synthetic DMARDs. The primary goal of this study was to assess the long-term safet